views
AutologousMatrix-induced Chondrogenesis Market, by Material Type (Collagen,Polyethylene Glycol, Polylactic-Co-Glycolic Acid, and Hyaluronic Acid), byApplication (Knee Cartilage, Elbow Cartilage, and Hip Cartilage), by Region(North America, Latin America, Europe, Asia Pacific, Middle East, And Africa) -Size, Share, Outlook, and Opportunity Analysis, 2019-2027
Autologous matrix-inducedchondrogenesis is an innovative treatment to repair articular cartilage damage.It is a one step process that uses the microfracturing method, which isfollowed by application of bilayer collagen I/III membrane by partiallyautologous fibrin glue. Increasing prevalence of bone and joint disorders suchas osteoporosis and arthritis, increasing sports-related injuries, and risingdemand for minimally-invasive surgery is driving the autologous matrix-inducedchondrogenesis market growth.
Autologous Matrix-induced ChondrogenesisMarket - Drivers
Increasing number of joint andbone disorders such as osteoporosis and arthritis globally is expected to drivethe autologous matrix-induced chondrogenesis market growth during the forecastperiod.
* The sample copy includes: Report Summary, Table ofContents, Segmentation, Competitive Landscape, Report Structure, Methodology.
Request a sample copyof this report: https://www.coherentmarketinsights.com/insight/request-sample/2748
For instance, according to theNational Center for Biotechnology Information (NCBI) 2016 report, over 200million people are suffering from osteoporosis worldwide in 2015. 1 in 3 womenover the age of 50 years and 1 in 5 men will experience osteoporosis fracturesin their lifetime.
Rising number of surgeries isexpected to drive the autologous matrix-induced chondrogenesis market growthduring the forecast period. For instance, according to American Academy ofOrthopaedic Surgeon (AAOS) 2019 report, around 267,000 knee replacements are performedeach year in the U.S.
Autologous Matrix-induced ChondrogenesisMarket - Restraints
Inefficient system ofreimbursement and high cost of cartilage replacement are major factorsrestraining growth of the autologous matrix-induced chondrogenesis market.Several health insurance companies do not insure AMIC procedure. For instance,according to Blue Cross Blue Shield of North Carolina 2019, for patientswithout health insurance, a total hip replacement usually costs between US$31,839 and US$ 44,816, with an average cost of US$ 39,299 in the U.S.
Browse ResearchReport: https://www.coherentmarketinsights.com/ongoing-insight/autologous-matrix-induced-chondrogenesis-market-2748
Autologous Matrix-inducedChondrogenesis Market - Regional Analysis
On the basis of region, theautologous matrix-induced chondrogenesis market is segmented into NorthAmerica, Latin America, Europe, Asia Pacific, Middle East, and Africa. NorthAmerica is expected to hold dominant position in the autologous matrix-induced chondrogenesismarket during the forecast period, owing to increasing sports-related injuriesand rising population. For instance, according to National Safety Council (NSC)report, in 2017, over 526,000 sports-related injuries were reported in the U.S.
Asia Pacific is expected towitness significant growth over the forecast period, owing to rising demand forminimally-invasive surgery in the region. For instance, according to theNational Center for Biotechnology Information, in 2017, minimally-invasive surgerywas carried out firstly in China. Laparoscopy surgery was one of the firsttypes of minimally-invasive surgery.
Autologous Matrix-inducedChondrogenesis Market - Competitive Landscape
Key players operating in theautologous matrix-induced chondrogenesis market include Biotissue AG,Arthro-Kinetics, JRL Orthopaedic Ltd, B Braun, Melsungen AG, Matricel GmbH,Geistlich Pharma AG, and Zimmer Biomet Holdings.
Buy-Now this researchreport: https://www.coherentmarketinsights.com/insight/buy-now/2748
AboutCoherent Market Insights:
CoherentMarket Insights is a prominent market research and consulting firm offering action-readysyndicated research reports, custom market analysis, consulting services, andcompetitive analysis through various recommendations related to emerging markettrends, technologies, and potential absolute dollar opportunity.
ContactUs:
mailto:sales@coherentmarketinsights.com
U.S.Office:
Name: Mr. Shah
CoherentMarket Insights 1001 4th Ave,
# 3200Seattle, WA 98154, U.S.
US : +1-206-701-6702
UK : +44-020-8133-4027
JAPAN : +050-5539-1737